跳至主要内容
临床试验/JPRN-jRCT1061230085
JPRN-jRCT1061230085招募中2 期

A study to determine the optimal dose of folic acid supplementation in patients with rheumatic diseases on methotrexate treatment

Shintaro Hirata0 个研究点目标入组 50 人开始时间: 2023年12月26日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • 1. Adult patients aged 18 years or older at the time of consent
  • 2. Patients who were diagnosed with rheumatic disease more than 12 weeks ago and have been receiving stable doses of methotrexate for more than 8 weeks
  • 3. Patients receiving folic acid 5 mg/week 24-48 hours after the last dose of methotrexate
  • 4. Patients whose written consent are obtained for participation in this study

排除标准

  • 1. Patients who have regularly taken supplements or health foods containing folic acid within 8 weeks before starting this study
  • 2. Patients who are lack of medication compliance due to cognitive impairment
  • 3. Patients who are unable to visit our hospital regularly during the 12-week study period
  • 4. Patients judged to be inappropriate by the principal investigator or sub-investigator

研究者

发起方
Shintaro Hirata

相似试验